Internal Medicine, Interventional Cardiology · Oakland, NJ
NPI
1124108808
Since 2006
Specialty
Internal Medicine, Interventional Cardiology
Code 207RI0011X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
43 Yawpo Ave
Oakland, NJ, 07436
Phone (201) 337-0066
Groups this clinician bills Medicare through
Medicare paid, 2024
$466K
6,866 services
Medicare patients, 2024
1,737
Average age 78
Drug cost, 2024
$2.5M
16,626 prescriptions
Company payments, 2025
$1,301
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David H Montgomery was code 93000 (electrocardiogram), 2,195 times for 1,305 patients. In total David H Montgomery billed 6,866 services in 59 codes, and Medicare paid $466K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2008-05-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93000 Electrocardiogram | Office | 2,195 | 1,305 | $11.37 | $25K |
| 99214 Office E&M - Established | Office | 2,128 | 1,257 | $98.49 | $210K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 794 | 731 | $13.94 | $11K |
| 93306 Echocardiography (TTE/TEE) | Office | 437 | 429 | $159.30 | $70K |
| 99232 Hospital E&M - Subsequent | Facility | 185 | 118 | $66.35 | $12K |
| 99091 E&M - Miscellaneous | Office | 120 | 55 | $44.58 | $5,349 |
| 99213 Office E&M - Established | Office | 97 | 75 | $63.77 | $6,185 |
| 93228 Electrocardiogram | Office | 93 | 91 | $20.29 | $1,887 |
| 93229 Electrocardiogram | Office | 93 | 91 | $742.99 | $69K |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 79 | 35 | $88.17 | $6,965 |
| 99204 Office E&M - New | Office | 71 | 71 | $126.02 | $8,948 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 70 | 54 | $54.43 | $3,810 |
| 93922 Duplex Scan - Extremity Arteries | Office | 66 | 62 | $62.52 | $4,126 |
| 93306 Echocardiography (TTE/TEE) | Facility | 65 | 64 | $57.26 | $3,722 |
| 93351 Echocardiography (TTE/TEE) | Office | 50 | 50 | $185.92 | $9,296 |
By year: 2022 $544K for 6,717 services; 2023 $564K for 6,556 services; 2024 $466K for 6,866 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 27 | 19 | $4.22 | $114 |
Medicare prescription drug claims, 2024
In 2024, the drug David H Montgomery prescribed most often to Medicare patients was Amlodipine Besylate, with 1,117 prescriptions and refills. In total David H Montgomery wrote 16,626 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,117 | 3,211 | 332 | $8,658 |
| Metoprolol Succinate Generic | 1,024 | 2,996 | 304 | $17K |
| Rosuvastatin Calcium Generic | 990 | 2,877 | 291 | $17K |
| Atorvastatin Calcium Generic | 984 | 2,841 | 287 | $12K |
| Ezetimibe Generic | 956 | 2,744 | 297 | $25K |
| Eliquis Apixaban | 838 | 1,548 | 183 | $878K |
| Valsartan Generic | 677 | 1,907 | 196 | $24K |
| Simvastatin Generic | 594 | 1,708 | 164 | $5,179 |
| Pravastatin Sodium Generic | 546 | 1,562 | 175 | $7,605 |
| Hydrochlorothiazide Generic | 395 | 1,096 | 125 | $2,782 |
| Spironolactone Generic | 385 | 1,044 | 118 | $4,221 |
| Losartan Potassium Generic | 358 | 1,049 | 103 | $3,674 |
| Lisinopril Generic | 354 | 1,008 | 104 | $3,472 |
| Metoprolol Tartrate Generic | 296 | 825 | 90 | $1,785 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 281 | 733 | 86 | $2,626 |
Brand drugs: 2,148 claims; generic drugs: 14,465 claims; opioid claims: 19.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David H Montgomery $1,301 ($1,301 in general payments such as food, travel and fees) from 20 companies. The largest payer was Novartis Pharmaceuticals Corporation with $219.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 12 | $219 |
| Novo Nordisk Inc NVO | 11 | $179 |
| Philips North America LLC PHG | 1 | $140 |
| Pfizer Inc. PFE | 6 | $108 |
| BridgeBio Pharma, Inc. BBIO | 5 | $87.39 |
| E.R. Squibb & Sons, L.L.C. BMY | 4 | $62.78 |
| Amgen Inc. AMGN | 4 | $60.78 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52.93 |
| Biotronik Inc. | 1 | $52.29 |
| Alnylam Pharmaceuticals Inc. ALNY | 3 | $50.01 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.